Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Cash equivalents & AFS marketable debt securities by Year
Cash equivalents & AFS marketable debt securities — Total amortized cost ($M) ($M)
Moderna Cash equivalents & AFS marketable debt securities: $5,533M in FY2025, down 27.3% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 5 (Cash, Cash Equivalents and Marketable Securities).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash equivalents & AFS marketable debt securities — Total amortized cost ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,533 | -27.3% | Form 10-Q (filed 2026-07-31) ↗ |
| FY2024 | Dec 31, 2024 | 7,614 | -27.6% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 10,519 | -32.0% | Form 10-K (filed 2025-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 15,479 | +43.7% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 10,774 | +311.4% | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 2,619 | +155.7% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,024 | -1.3% | Form 10-K (filed 2021-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 1,037 | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Moderna Cash equivalents & AFS marketable debt securities ($M), annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/afs-amort-cost
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.